Charles Atkinson

Array ( [id] => 498158 [patent_doc_number] => 07208589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-24 [patent_title] => 'Flea ultraspiracle nucleic acid molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/855541 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24715 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/208/07208589.pdf [firstpage_image] =>[orig_patent_app_number] => 10855541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965967 [patent_doc_number] => 20080108787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Purification of Insulin-Like Material by Reverse Phase Chromatography' [patent_app_type] => utility [patent_app_number] => 11/597430 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4763 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108787.pdf [firstpage_image] =>[orig_patent_app_number] => 11597430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426524 [patent_doc_number] => 20040265785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Method for treating materials of biological origin, and collagen-elastin product' [patent_app_type] => new [patent_app_number] => 10/853766 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4853 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265785.pdf [firstpage_image] =>[orig_patent_app_number] => 10853766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432422 [patent_doc_number] => 20040209818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Immunomodulating polymers' [patent_app_type] => new [patent_app_number] => 10/848779 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21347 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209818.pdf [firstpage_image] =>[orig_patent_app_number] => 10848779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236446 [patent_doc_number] => 20070128603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)' [patent_app_type] => utility [patent_app_number] => 10/558297 [patent_app_country] => US [patent_app_date] => 2004-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37802 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128603.pdf [firstpage_image] =>[orig_patent_app_number] => 10558297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106923 [patent_doc_number] => 20070065801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (seotonin) receptor 4 (5-ht4)' [patent_app_type] => utility [patent_app_number] => 10/557887 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 33222 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065801.pdf [firstpage_image] =>[orig_patent_app_number] => 10557887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190163 [patent_doc_number] => 20040204362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Alpha-conotoxin peptides' [patent_app_type] => new [patent_app_number] => 10/839179 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16223 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204362.pdf [firstpage_image] =>[orig_patent_app_number] => 10839179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275076 [patent_doc_number] => 20040234527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Peptides for use as translocation factors' [patent_app_type] => new [patent_app_number] => 10/479166 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8939 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234527.pdf [firstpage_image] =>[orig_patent_app_number] => 10479166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918699 [patent_doc_number] => 20050096260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Metal complex-protein composite and oxidation catalyst' [patent_app_type] => utility [patent_app_number] => 10/831320 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3568 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096260.pdf [firstpage_image] =>[orig_patent_app_number] => 10831320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434182 [patent_doc_number] => 20040266685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Use of relaxin to treat diseases related to vasoconstriction' [patent_app_type] => new [patent_app_number] => 10/819039 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22675 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266685.pdf [firstpage_image] =>[orig_patent_app_number] => 10819039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953906 [patent_doc_number] => 06958320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-25 [patent_title] => 'Sel-12 related methods' [patent_app_type] => utility [patent_app_number] => 10/811199 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 19785 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958320.pdf [firstpage_image] =>[orig_patent_app_number] => 10811199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 52785 [patent_doc_number] => 07771996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'FVII or FVIIa variants' [patent_app_type] => utility [patent_app_number] => 10/549506 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16940 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771996.pdf [firstpage_image] =>[orig_patent_app_number] => 10549506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 556581 [patent_doc_number] => 07160988 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-09 [patent_title] => 'Altering protein functional properties through terminal fusions' [patent_app_type] => utility [patent_app_number] => 10/795062 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9565 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160988.pdf [firstpage_image] =>[orig_patent_app_number] => 10795062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019420 [patent_doc_number] => 20050221439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Genes of an otitis media isolate of haemophilus influenzae' [patent_app_type] => utility [patent_app_number] => 10/795159 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26629 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221439.pdf [firstpage_image] =>[orig_patent_app_number] => 10795159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057590 [patent_doc_number] => 20070060512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Dipeptidyl-peptidase protected protein' [patent_app_type] => utility [patent_app_number] => 10/547510 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27221 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060512.pdf [firstpage_image] =>[orig_patent_app_number] => 10547510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252313 [patent_doc_number] => 20050142561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Intracellular signaling pathways in diabetic subjects' [patent_app_type] => utility [patent_app_number] => 10/791219 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 34749 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142561.pdf [firstpage_image] =>[orig_patent_app_number] => 10791219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 708140 [patent_doc_number] => 07060803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Metal complex-protein composite and hydrogenation catalyst' [patent_app_type] => utility [patent_app_number] => 10/790060 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3351 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060803.pdf [firstpage_image] =>[orig_patent_app_number] => 10790060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168784 [patent_doc_number] => 07666996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Casein derived peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/788400 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 33 [patent_no_of_words] => 34791 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666996.pdf [firstpage_image] =>[orig_patent_app_number] => 10788400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305866 [patent_doc_number] => 20040116329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Inhibition of proteasomes to prevent restenosis' [patent_app_type] => new [patent_app_number] => 10/470533 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2824 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116329.pdf [firstpage_image] =>[orig_patent_app_number] => 10470533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190147 [patent_doc_number] => 20040204359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Methods and compositions in treating pain and painful disorders using 16386,15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620' [patent_app_type] => new [patent_app_number] => 10/768158 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49251 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204359.pdf [firstpage_image] =>[orig_patent_app_number] => 10768158 [rel_patent_id] =>[rel_patent_doc_number] =>)